Institute Activities and Advances
Many programs within the NICHD's Division of Intramural Population Health Research (DIPHR), Division of Extramural Research (DER), and Division of Intramural Research (DIR) conduct and support research on pregnancy. Researchers investigate a wide variety of topics related to improving the health of mothers and their fetuses, from before conception to the weeks and months after birth. Details about studies in the areas of preconception care and prenatal care, pregnancy complications, and labor and delivery follow below.
Preconception Care and Prenatal Care
NICHD seeks to increase awareness about the importance of preconception care and prenatal care to promote a healthy pregnancy and the best outcomes for mothers and babies. Areas of investigation include:
- Evaluating maternal health during pregnancy. Studies supported by the Pregnancy and Perinatology Branch (PPB), within the NICHD's DER, focus on the pathogenesis of symptomatic and asymptomatic maternal infections, the state of women's mental health during pregnancy, and the etiology and pathophysiology of sleep-disordered breathing in pregnancy.
- Evaluating techniques to develop and refine prenatal screenings. The DER's Intellectual and Developmental Disabilities Branch supports studies leading to the development and refinement of screening methods for conditions leading to intellectual and developmental disabilities.
- Investigating the role of nutrition during pregnancy. Researchers supported by the NICHD and the National Institute of Neurological Disorders and Stroke have reported new findings related to the interaction between folic acid supplementation, an important tool in prenatal care, and genetic pathways that could inform strategies to optimize the prevention of neural tube defects (NTDs) such as spina bifida (PMID: 20843827).
In addition, researchers supported by the Pediatric Growth and Nutrition Branch of the DER are studying iron-deficiency anemia in newborns to determine if identifying and treating iron deficiency in pregnancy can reduce this prevalent problem.
- Establishing a national standard for fetal growth. A current trial led by the NICHD's DIPHR focuses on establishing a standard for both singleton and multiple pregnancies. Researchers will measure fetal growth via ultrasound, working with 2,400 women from their first trimester through delivery.
- Studying medication use during pregnancy. The Effects of Aspirin in Gestation and Reproduction (EAGeR) Study, supported by the DIPHR, is examining the therapeutic value of low-dose aspirin in prenatal care. The research will analyze the effects of low-dose aspirin in combination with the intake of folic acid, compared with folic acid alone, on the incidence of miscarriage and other outcomes.
The DER's Obstetric and Pediatric Pharmacology and Therapeutics Branch promotes research to improve the safety and effectiveness of medications for pregnant women. Some current studies include the study of clonidine to treat high blood pressure and metformin for the treatment of diabetes. In addition, a recent study on the effectiveness of Dilectin for nausea and vomiting found that the medication resulted in dramatically improved symptoms compared to placebo (PMID: 20843504).
- Evaluating effects of drinking alcohol and smoking tobacco on pregnancy outcomes. The Pregnancy and Perinatology Branch in the NICHD DER is studying alcohol use during pregnancy and its effects on infants. Other studies through the Prenatal Alcohol and SIDS and Stillbirth (PASS) Network are investigating the impact of alcohol use and tobacco smoking, both before and during pregnancy, on risk for Sudden Infant Death Syndrome (SIDS).
In addition, an animal study by researchers in the Unit on Perinatal and Developmental Neurobiology, within the DIR, found that neuroprotective peptides may reduce changes in the immune system that are caused by prenatal exposure to alcohol. Fetal alcohol syndrome (FAS) and related disorders occur in children of mothers who consumed alcohol during pregnancy. These disorders often involve lifelong intellectual disability. Although many children with FAS or related conditions also have facial abnormalities, in other children the only sign of the disease is cognitive or behavioral impairment. Researchers aren't sure exactly how many children in the United States have FAS or related conditions, but estimates from the Centers for Disease Control and Prevention range from 2 to 15 cases for every 10,000 live births. Although fetal alcohol disorders can be prevented if women do not drink alcohol during pregnancy, treatments are needed to help reverse the effects of alcohol on the fetus and to help children who are born with the condition. To better understand exactly how alcohol can have such devastating effects on the fetus during early development, scientists treated pregnant mice with alcohol and then measured certain substances that show the body's immune response. The researchers found that some, but not all, of the immune system indicators were affected by alcohol. In a second experiment, scientists injected mice with a specific peptide that may reduce the changes in the immune system caused by alcohol, and then injected the mice with alcohol. They suspected that the mice treated first with the peptide would not show changes in the immune system, and that was exactly what happened. These results help scientists understand the effects of alcohol damage and may help them identify and test new interventions. (PMID: 23174390)
- Preterm birth. The NICHD served as the scientific lead for the Surgeon General's Conference on Preventing Preterm Birth in 2008, which developed the national agenda and action plan aimed at preventing preterm birth. This topic is an active research focus for the NICHD. The following current research efforts are supported by the PPB:
Researchers participating in the Maternal-Fetal Medicine Units Network, also supported by the PPB, found that use of progesterone by women at risk for preterm birth due to a prior preterm birth reduces the chances of a subsequent preterm birth by one-third.
- Evaluating whether treatments with antenatal steroids between 34 and 36 weeks of pregnancy will decrease infants' need for oxygen support
- Investigating the mechanisms of disease responsible for preterm birth, including how certain maternal antibodies might induce labor
- Studying women who are pregnant for the first time, with the goal of identifying factors in women who may be at risk for complications, including pregnancy-induced hypertension, preterm delivery, and low-birth-weight infants, during their first pregnancy.
NICHD research formed the basis of a recent change to the gestational period within a pregnancy that is recognized as “term” or “full term.” According to the new designations :
NICHD research documented poorer health outcomes, including a 20% greater risk of breathing, feeding, and temperature problems, among babies born at 37 and 38 weeks gestation compared to those born at 39 weeks or later. These findings contributed to the designation changes (PMID: 23645117).
- Early term is defined as 37 weeks through 38 weeks and 6 days.
- Full term is defined as 39 weeks through 40 weeks and 6 days.
- Late term is 41 weeks through 41 weeks and 6 days.
- Postterm is 42 weeks and beyond.
- Gestational diabetes. The DIPHR Epidemiology Branch is currently studying the increased risk of hypertension in women with gestational diabetes mellitus. In addition, researchers in this Branch recently reported that women with gestational diabetes may be able to prevent the development of type 2 diabetes by following a healthy diet after pregnancy. Read more about this finding.
Another study, called the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Follow-up Study, is supported by the PNGB. This study will explore whether elevated blood sugar during pregnancy influences later levels of body fat in children and development of diabetes in mothers following birth.
In March 2013, the NICHD sponsored the NIH Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus. The expert panel recommended following the current two-step process for diagnosing GDM as opposed to adopting a one-step process.
- Preeclampsia. Studies are ongoing to determine whether abnormal levels of certain substances in the blood can predict preeclampsia. NICHD researchers and others have found that women who develop preeclampsia have higher levels of a substance called soluble fms-like tyrosine kinase 1 (sFlt1) and lower levels of placental growth factor and vascular endothelial growth factor than women who do not develop preeclampsia. Read more about preeclampsia research supported by the NICHD.
- Infections. Researchers investigating the expression and regulation of a group of innate immune receptors, called Toll-like receptors (TLRs), discovered that TLRs may play a role in infection-associated pregnancy complications by regulating the infection-induced inflammatory responses at the maternal-fetal interface.
- Pregnancy loss (miscarriage and stillbirth). Another recent study supported by the PPB found that women experiencing two stressful life events in the year before their delivery were 40% more likely to have a stillbirth than were women who reported no such events.
Labor and Delivery
- The Consortium on Safe Labor, within the DIPHR Epidemiology Branch, is evaluating the appropriateness of relying on the Friedman curve, which has traditionally been used to plot hours of labor against cervical dilation in centimeters, to guide decision making. This study is evaluating labor progression to determine the appropriate time to perform a cesarean section in women with protracted labor and/or arrest. Researchers are tracking trends in preterm deliveries, practices such as induced labor, and how environmental and other factors may influence fertility, pregnancy, and pregnancy outcomes over time. Results from this study suggest that labor today may last longer than it did for women 50 years ago.
- In addition, the Maternal and Pediatric Infectious Disease Branch supports research examining mother-to-child transmission of HIV and how this can be prevented during pregnancy and labor. Current research includes:
- Studies on the epidemiology of HIV infection and complications in pregnant women and the safety of using new medications during pregnancy
- Investigating interventions to identify, prevent, and treat women at risk for obstetric fistula
- In 2006, an NIH State-of-the-Science Conference on Cesarean Delivery on Maternal Request, formed in response to the growing trend in requests for cesarean deliveries, assessed the potential benefits and risks of requested cesarean deliveries versus vaginal deliveries. Read the conference statement (PDF - 3.59 MB).
- Current studies in the Developmental Biology and Structural Variation Branch of the DER include immunobiology of the placenta and maternal-fetal interactions. The Branch also funds opportunities for and studies on understanding embryonic development and the origin and development of structural birth defects.
- The National Center for Medical Rehabilitation Research funds the Center for Research on Women with Disabilities (CROWD), which completed the in 1999. That report found that pregnant women with disabilities face significant challenges in finding health care providers who are knowledgeable about their disability to help them manage their pregnancy .
Other Activities and Advances
To achieve its goals for research on pregnancy and related disorders, the NICHD supports a variety of programs, networks, and centers. A number of examples are included below.
- The NICHD created the National Child and Maternal Health Education Program (NCMHEP) in 2008 to provide a forum for reviewing, translating, and disseminating new research in maternal and child health. A coalition of health care provider associations, federal agencies, nonprofit organizations, and other partners pinpoint one issue pertaining to maternal and child health on which to focus for a set period of time, typically 12 to 18 months. The first focus area is Late Preterm Birth and Elective Term Deliveries .
- Established in 2003 by the PPB, the Stillbirth Collaborative Research Network is currently studying stillbirth cases at five clinical sites around the country and completing a case-control study that is the first large stillbirth study in the United States to simultaneously include population-based controls and complete fetal autopsy and placental pathology examinations.
- The PPB created the Maternal-Fetal Medicine Units (MFMU) Network in 1986 to address the issue of preterm birth. The Network includes 14 clinical centers and a data coordinating center. More than 45 clinical trials have been completed or are in progress.
- Created in 2001, the Maternal-Fetal Surgery Network, also part of the PPB, has validated positive outcomes of in utero surgery to repair myelomeningocele, the most severe form of spina bifida. The clinical trial that did this, the Management of Myelomeningocele Study, was named the 2012 "Trial of the Year" by the Society for Clinical Trials.
- The Birth Defects Research Group is a multicenter, multidisciplinary group led by the NICHD to investigate the etiology of birth defects, particularly NTDs. The group was the first to discover that homocysteine levels were elevated for women carrying fetuses affected by NTDs. This group is supported by the NICHD's DIPHR.
- The NICHD supports the Prenatal Alcohol and SIDS and Stillbirth (PASS) Network, in partnership with the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Deafness and Other Communication Disorders, with the aim of studying the effects of prenatal alcohol exposure on the risk of SIDS, stillbirth, and other adverse outcomes.
- Supported by the Obstetric and Pediatric Pharmacology and Therapeutics Branch, the Obstetric-Fetal Pharmacology Research Unit Network provides expertise for clinical trials of medication to treat various conditions in pregnancy, such as gestational diabetes, severe nausea, high blood pressure, and preterm labor.
- The Global Network for Women's and Children's Health Research was created in 2001 as a public-private partnership between the NICHD, the Center for Research for Mothers and Children, and the Bill and Melinda Gates Foundation. The Global Network builds domestic and international partnerships to address maternal and newborn health challenges. Co-funded by the NICHD Maternal and Pediatric Infectious Disease Branch (MPIDB), the International Maternal, Pediatric, Adolescent AIDS Clinical Trial (IMPAACT) Network focuses on potential therapies for HIV infection, including clinical trials of HIV/AIDS interventions for and prevention of mother-to-child transmission.
- In addition, since 1987 the MPIDB has supported the NICHD Domestic and International Pediatric and Maternal HIV Clinical Studies Network (NICHD Network), which leads and supports clinical trials related to preventing and treating HIV infections and their complications in infants, children, and pregnant women.
- Co-funded by the PPB, the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) evaluates first-time mothers to provide information about potential adverse outcomes like preterm birth, preeclampsia, and fetal growth restriction.
- As a part of the NICHD Health Disparities Seminar Series, the Institute hosted the Racial and Ethnic Disparities in Pregnancy Outcomes: Exploring the Role of Paternal Involvement workshop in July 2012 to address the role of prospective fathers in pregnancy outcomes. The workshop was organized by the Office of Health Equity.